Samuel Lentz to Medroxyprogesterone Acetate
This is a "connection" page, showing publications Samuel Lentz has written about Medroxyprogesterone Acetate.
Connection Strength
0.015
-
Whitney CW, Brunetto VL, Zaino RJ, Lentz SS, Sorosky J, Armstrong DK, Lee RB. Phase II study of medroxyprogesterone acetate plus tamoxifen in advanced endometrial carcinoma: a Gynecologic Oncology Group study. Gynecol Oncol. 2004 Jan; 92(1):4-9.
Score: 0.015